Minotab (Minocycline Hydrochloride)

Minocycline, the active ingredient in Minotab, is a tetracycline antibiotic presented as an oral tablet for systemic use. It is employed to treat bacterial infections such as acne vulgaris, respiratory tract infections, urinary tract infections, and skin and soft‑tissue infections in adolescents and adults.

GNH USA supplies Minotab as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory‑approved batches for global distribution.

Minocycline is a tetracycline antibiotic used to manage bacterial infections affecting several organ systems.

- Acne vulgaris: reduces inflammatory lesions and bacterial colonization of the skin. - Respiratory tract infections: treats community‑acquired pneumonia and sinusitis caused by susceptible organisms. - Urinary tract infections: eradicates common uropathogens in uncomplicated cases. - Skin and soft‑tissue infections: combats cellulitis, wound infections and other dermal bacterial conditions.

Minocycline may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Nausea: mild gastrointestinal upset. - Photosensitivity: increased skin reaction to sunlight. - Dizziness: transient vertigo or light‑headedness. - Skin discoloration: gray‑blue pigmentation of the skin or nails.

Serious or Rare Side Effects: - Stevens‑Johnson syndrome: severe mucocutaneous reaction. - Hepatic toxicity: elevated liver enzymes or hepatitis. - Anaphylaxis: acute allergic reaction with airway compromise.

Before prescribing Minotab, consider the following safety measures.

- Pregnancy: Category D – use only if benefits outweigh risks. - Renal impairment: dose adjustment may be required; monitor renal function. - Hepatic impairment: caution in patients with liver disease. - Concomitant photosensitizing agents: avoid excessive sun exposure. - Anticoagulant therapy: monitor INR as minocycline may enhance anticoagulant effect. - Store below 25°C: keep in the original container, protect from moisture and light.

Minotab can interact with several medicines; review patient medication lists.

Major Interactions (Avoid): - Isotretinoin: increased risk of intracranial hypertension. - Antacids containing aluminum, calcium, magnesium, or iron: reduce minocycline absorption. - Warfarin: potentiation of anticoagulant effect; monitor INR closely.

Moderate Interactions (Monitor Closely): - Oral contraceptives: reduced efficacy, consider alternative contraception. - NSAIDs: may increase risk of renal toxicity. - Phenytoin: may decrease minocycline plasma levels.